Abdelrahman Y Sherif (Gamaleldin I Harisa)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Metabolic Syndrome

High Throughput

Combination Therapy

Top Venues

Molecules (Basel, Switzerland)

AAPS PharmSciTech

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Abdelrahman Y Sherif, Doaa Hasan Alshora, Mohamed Abbas Ibrahim, Adel Jreebi
Development and Evaluation of Solidified Supersaturated SNEDDS Loaded with Triple Combination Therapy for Metabolic Syndrome. AAPS PharmSciTech 25 (7) (2024)
Abdelrahman Y Sherif, Gamaleldin I Harisa, Ahmad Abdul-Wahhab Shahba, Fars Kaed Alanazi, Wajhul Qamar
Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer. Molecules (Basel, Switzerland) 28 (1) (2023)
Ehab M Elzayat, Abdelrahman Y Sherif, Fahd A Nasr, Mohamed W Attwa, Doaa H Alshora, Sheikh Fayaz Ahmad, Ali S Alqahtani
Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles. Materials (Basel, Switzerland) 16 (15) (2023)
Abdelrahman Y Sherif, Gamaleldin I Harisa, Ahmad Abdul-Wahhab Shahba, Fars Kaed Alanazi, Wajhul Qamar
Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer. Molecules (Basel, Switzerland) 28 (1) (2023)
Abdelrahman Y Sherif, Ahmad Abdul-Wahhab Shahba
Development of a Multifunctional Oral Dosage Form via Integration of Solid Dispersion Technology with a Black Seed Oil-Based Self-Nanoemulsifying Drug Delivery System. Biomedicines 11 (10) (2023)
Abdelrahman Y Sherif, Gamaleldin I Harisa, Ahmad Abdul-Wahhab Shahba, Fars Kaed Alanazi, Wajhul Qamar
Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer. Molecules (Basel, Switzerland) 28 (1) (2023)
Abdelrahman Y Sherif, Abdelrahman Y Sherif, Ahmad Abdul-Wahhab Shahba, Fahd A Nasr, Ehab I Taha, Ali S Alqahtani
Assembly of nanostructured lipid carriers loaded gefitinib and simvastatin as hybrid therapy for metastatic breast cancer: Codelivery and repurposing approach. Drug development research (2023)
Abdelrahman Y Sherif, Gamaleldin I Harisa, Ahmad Abdul-Wahhab Shahba, Fars Kaed Alanazi, Wajhul Qamar
Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer. Molecules (Basel, Switzerland) 28 (1) (2023)
Ahmad Abdul-Wahhab Shahba, Abdelrahman Y Sherif, Ehab M Elzayat, Mohsin Kazi
Combined Ramipril and Black Seed Oil Dosage Forms Using Bioactive Self-Nanoemulsifying Drug Delivery Systems (BIO-SNEDDSs). Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Ahmad Abdul-Wahhab Shahba, Zaid Alashban, Ibrahim A Sales, Abdelrahman Y Sherif, Osman Yusuf
Development and Evaluation of Interactive Flipped e-Learning (iFEEL) for Pharmacy Students during the COVID-19 Pandemic. International journal of environmental research and public health 19 (7) (2022)